{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:13:20Z","timestamp":1784333600088,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["20200065"],"award-info":[{"award-number":["20200065"]}],"id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Proton pump inhibitors (PPIs) are effective in treating gastroesophageal reflux, peptic ulcers, and esophagitis. However, the long-term use of PPIs by older adults is associated with adverse health outcomes. There is limited evidence about older adults\u2019 awareness of long-term PPI use and its associated adverse effects. This study aimed to assess older adults\u2019 awareness of the adverse effects of the long-term use of PPIs, and their willingness to stop PPI use given of the risks and benefits of PPI use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>this cross-sectional study was conducted on a convenience sample of 120 older adults from three local healthcare centers located in Irbid, Jordan. Older adults\u2019 awareness of PPI use was measured using the Patients\u2019 Perceptions of Proton Pump Inhibitor Risks and Attempts at Discontinuation Survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      the majority of the participating older adults were not familiar with any reports linking long-term PPI use with adverse effects, reported no concerns related to the chronic use of PPIs, and reported that they had not discussed the benefits and risks of PPI use with their primary care providers (PCPs). Although the majority of the participants had not previously attempted to stop using PPIs, the majority expressed a willingness to stop PPIs due to their adverse effects, especially if advised to do so by a PCP. The factors associated with the long-term use of PPIs included age, indications for gastrointestinal reflux disease (GERD), improvement of GERD symptoms, and the willingness to reduce or stop PPIs. Being advised by a PCP to stop PPIs (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.049) and having increased concerns about the adverse effects of long-term PPI use (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) were the only two statistically significant predictors of previous attempts to stop PPIs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>concerns regarding the adverse effects of long-term PPI use were associated with attempts to stop PPIs, especially in cases where this was recommended by a PCP. Discussions between PCPs and patients regarding the risks and benefits of PPIs are necessary in order to ensure that patients do not make inappropriate decisions regarding ongoing PPI therapy. Careful evaluation of the long-term use of PPIs among older adults is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-020-01844-w","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T09:03:09Z","timestamp":1603962189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Community-dwelling older adults\u2019 awareness of the inappropriate use of proton pump inhibitors"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4747-4217","authenticated-orcid":false,"given":"Mohammad","family":"Rababa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Rababa\u2019h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"issue":"4","key":"1844_CR1","first-page":"267","volume":"71","author":"PV Nguyen","year":"2018","unstructured":"Nguyen PV, Tamaz R. Inappropriate prescription of proton pump inhibitors in a community setting. Can J Hosp Pharm. 2018;71(4):267\u201371.","journal-title":"Can J Hosp Pharm"},{"issue":"7","key":"1844_CR2","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/jgs.15385","volume":"66","author":"J Zirk-Sadowski","year":"2018","unstructured":"Zirk-Sadowski J, Masoli JA, Delgado J, Hamilton W, Strain WD, Henley W, Melzer D, Ble A. Proton-pump inhibitors and long-term risk of community-acquired pneumonia in older adults. J Am Geriatr Soc. 2018;66(7):1332\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"1844_CR3","doi-asserted-by":"crossref","unstructured":"Voukelatou P, Vrettos I, Emmanouilidou G, Dodos K, Skotsimara G, Kontogeorgou D, Kalliakmanis A. Predictors of inappropriate proton pump inhibitors use in elderly patients. Curr Gerontol Geriatr Res. 2019;2019.","DOI":"10.1155\/2019\/7591045"},{"issue":"5","key":"1844_CR4","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/gut.2004.051821","volume":"54","author":"J Dent","year":"2005","unstructured":"Dent J, El-Serag HB, Wallander M, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54(5):710\u20137.","journal-title":"Gut."},{"issue":"4","key":"1844_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","volume":"152","author":"DE Freedberg","year":"2017","unstructured":"Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017;152(4):706\u201315.","journal-title":"Gastroenterology."},{"issue":"9","key":"1844_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/2042098617715381","volume":"8","author":"ML Maes","year":"2017","unstructured":"Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence. Ther Adv Drug Saf. 2017;8(9):273\u201397.","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"1844_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12913-018-3358-5","volume":"18","author":"H Luo","year":"2018","unstructured":"Luo H, Fan Q, Xiao S, Chen K. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital. BMC Health Serv Res. 2018;18(1):537.","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"1844_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s12603-015-0642-5","volume":"20","author":"RO Schepisi","year":"2016","unstructured":"Schepisi RO, Fusco S, Sganga F, Falcone B, Vetrano DL, Abbatecola A, Corica F, Maggio M, Ruggiero C, Fabbietti P, Corsonello A. Inappropriate use of proton pump inhibitors in elderly patients discharged from acute care hospitals. J Nutr Health Aging. 2016;20(6):665\u201370.","journal-title":"J Nutr Health Aging"},{"key":"1844_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176:238\u201346.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1844_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.14740\/gr944w","volume":"11","author":"JE Kurlander","year":"2018","unstructured":"Kurlander JE, Kolbe M, Rubenstein JH, Richardson CR, Heisler M, Weissman A, De Vries R, Saini SD. Internists\u2019 perceptions of proton pump inhibitor adverse effects and impact on prescribing practices: results of a nationwide survey. Gastroenterol Res. 2018;11(1):11\u20137.","journal-title":"Gastroenterol Res"},{"issue":"3","key":"1844_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3109\/13814788.2013.844787","volume":"20","author":"M Wermeling","year":"2014","unstructured":"Wermeling M, Himmel W, Behrens G, Ahrens D. Why do GPs continue inappropriate hospital prescriptions of proton pump inhibitors? A qualitative study. Eur J Gen Pract. 2014;20(3):174\u201380.","journal-title":"Eur J Gen Pract"},{"issue":"2","key":"1844_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.14309\/ajg.0000000000000061","volume":"114","author":"JE Kurlander","year":"2019","unstructured":"Kurlander JE, Kennedy JK, Rubenstein JH, Richardson CR, Krein SL, De Vries R, Saini SD. Patients' perceptions of proton pump inhibitor risks and attempts at discontinuation: a national survey. Am J Gastroenterol. 2019;114(2):244\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"1844_CR13","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1007\/s10620-010-1209-2","volume":"55","author":"WD Chey","year":"2010","unstructured":"Chey WD, Mody RR, Izat E. Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement? Dig Dis Sci. 2010;55(12):3415\u201322.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1844_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/apt.15522","volume":"51","author":"G Ghosh","year":"2020","unstructured":"Ghosh G, Schnoll-Sussman F, Mathews S, Katz PO. Reported proton pump inhibitor side effects: what are physician and patient perspectives and behaviour patterns? Aliment Pharmacol Ther. 2020;51(1):121\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"1844_CR15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00228-017-2273-8","volume":"73","author":"H Juntunen","year":"2017","unstructured":"Juntunen H, Taipale H, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S, Tiihonen M. Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer\u2019s disease. Eur J Clin Pharmacol. 2017;73(9):1149\u201358.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1844_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/pds.4135","volume":"26","author":"SM Wallerstedt","year":"2017","unstructured":"Wallerstedt SM, Fastbom J, Linke J, Vitols S. Long-term use of proton pump inhibitors and prevalence of disease-and drug-related reasons for gastroprotection\u2014a cross-sectional population-based study. Pharmacoepidemiol Drug Saf. 2017;26(1):9\u201316.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1844_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12877-018-0926-9","volume":"18","author":"M Bazargan","year":"2018","unstructured":"Bazargan M, Smith JL, King EO. Potentially inappropriate medication use among hypertensive older African-American adults. BMC Geriatr. 2018;18(1):238.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1844_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12882-016-0325-4","volume":"17","author":"P Arora","year":"2016","unstructured":"Arora P, Gupta A, Golzy M, Patel N, Carter RL, Jalal K, Lohr JW. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease. BMC Nephrol. 2016;17(1):112.","journal-title":"BMC Nephrol"},{"issue":"suppl_7","key":"1844_CR19","doi-asserted-by":"publisher","first-page":"vii11","DOI":"10.1093\/annonc\/mdt268","volume":"24","author":"RR Hajjar","year":"2013","unstructured":"Hajjar RR, Atli T, Al-Mandhari Z, Oudrhiri M, Balducci L, Silbermann M. Prevalence of aging population in the Middle East and its implications on cancer incidence and care. Ann Oncol. 2013;24(suppl_7):vii11\u201324.","journal-title":"Ann Oncol"},{"issue":"3","key":"1844_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s12126-016-9244-8","volume":"42","author":"S Hussein","year":"2017","unstructured":"Hussein S, Ismail M. Ageing and elderly care in the Arab region: policy challenges and opportunities. Ageing Int. 2017;42(3):274\u201389.","journal-title":"Ageing Int"},{"issue":"1","key":"1844_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12877-019-1102-6","volume":"19","author":"E Manias","year":"2019","unstructured":"Manias E, Bucknall T, Hughes C, Jorm C, Woodward-Kron R. Family involvement in managing medications of older patients across transitions of care: a systematic review. BMC Geriatr. 2019;19(1):95.","journal-title":"BMC Geriatr"},{"issue":"4","key":"1844_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3928\/00989134-20151218-04","volume":"42","author":"M Rababa","year":"2015","unstructured":"Rababa M, Al-Ghassani AA, Kovach CR, Dyer EM. Proton pump inhibitors and the prescribing cascade. J Gerontol Nurs. 2015;42(4):23\u201331.","journal-title":"J Gerontol Nurs"},{"issue":"7","key":"1844_CR23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40261-017-0519-y","volume":"37","author":"L Fisher","year":"2017","unstructured":"Fisher L, Fisher A. Acid-suppressive therapy and risk of infections: pros and cons. Clin Drug Investig. 2017;37(7):587\u2013624.","journal-title":"Clin Drug Investig"},{"issue":"2","key":"1844_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/jgh.12065","volume":"28","author":"A Deshpande","year":"2013","unstructured":"Deshpande A, Pasupuleti V, Thota P, Pant C, Mapara S, Hassan S, Rolston DD, Sferra TJ, Hernandez AV. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. J Gastroenterol Hepatol. 2013;28(2):235\u201342.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-020-01844-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12877-020-01844-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-020-01844-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T11:05:04Z","timestamp":1604228704000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-020-01844-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1186\/s12877-020-01844-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-25735\/v1","asserted-by":"object"}]},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,29]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved (IRB approval # 749\u20132019) by the Institutional Review Board (IRB) department of Jordan University of Science and Technology and the administrative office of the following healthcare centers: King Abdullah University Health Center, As-Sarih Health Center, and Howarah Health Center. Written informed consent was obtained from all of the participants included in the study prior to data collection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"431"}}